Business Strategies

An Innovator's Guide for Integrating Business and Market Access Considerations in Successful Commercialization Strategy

Tuesday, September 28, 2021

1:30 PM – 2:30 PM ET

Location: Virtual

Virtual Moderator(s)

Laurel Sweeney

Principal
Access Strategies, LLC

Virtual Speaker(s)

Amy Siegel

Co-Founder and Managing Partner
S2N Health
Kumar Dharmarajan, MD, MBA

Chief Scientific Officer and Associate Chief Medical Officer
Clover Health
Aaron Sandoski

Managing Director
Norwich Ventures, Partner at Medtech Convergence Fund

Turning a great technology or digital solution into a commercial success requires a multitude of inputs that must work together. Reimbursement and market access are critically important factors, but so are the business model and market positioning, all of which must align with the regulatory and product development pathway. With so many things to consider in creating the go-to-market strategy, what comes first? How can the perspectives of all the clinical and financial stakeholders be understood and anticipated? How important is market size in selecting the commercial entry point? What will de-risk the market opportunity for investors and convince them that my technology is worth funding? In this session, panelists will address these questions from the payer, user and investor perspectives to provide companies with a credible roadmap for realizing the value of their innovations.